Press coverage of hormone replacement therapy and menopause

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 153, Issue 1, 2010, Pages 56-61

  Colombo, Cinzia ^a   Mosconi, Paola ^a   Buratti, Maria Grazia ^a   Liberati, Alessandro ^b   Donati, Serena ^c   Mele, Alfonso ^c   Satolli, Roberto ^d  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d Zadig Scientific Publisher   (Italy)

Author keywords

Hormone replacement therapy; Informed decision making; Menopause; Press coverage

Indexed keywords

ARTICLE; HORMONE SUBSTITUTION; INFORMATION DISSEMINATION; ITALY; MENOPAUSAL SYNDROME; MENOPAUSE; PHYSICIAN; PRIORITY JOURNAL; PUBLICATION; RISK ASSESSMENT;

EID: 77958175855     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2010.07.026     Document Type: Article

References (34)

1. L.M. Schwartz, and S. Woloshin The media matter: a call for straightforward medical reporting Ann Intern Med 140 2004 226 228
2. R. Moynihan, L. Bero, and D. Ross-Degnan Coverage by the news of the benefits and risks of medications N Engl J Med 342 2000 1645 1650
3. L.M. Schwart, S. Woloshin, and L. Baczek Media coverage of scientific meetings: too much, too soon? JAMA 287 2002 2859 2863
4. A. Cassels, A. Hughes, C. Cole, B. Mintzes, J. Lexchin, and J.P. McCormack Drugs in the news: an analysis of Canadian newspaper coverage of new prescription drugs CMAJ 168 2003 1133 1137
5. R. Grilli, C. Ramsay, and S. Minozzi Mass media intervention: effects on health service utilization Cochrane Database Syst Rev 1 2002 Art. No.: CD000389, doi:10.1002/14651858.CD000389
6. M. Kelaher, J. Cawson, J. Miller, A. Kavanagh, D. Dunt, and D.M. Studdert Use of breast cancer screening and treatment services by Australian women aged 25-44 years following Kylie Minogue's breast cancer diagnosis Int J Epidemiol 37 2008 1326 1332
7. Writing Group for the Women's Health Initiative Investigators Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial JAMA 288 2002 321 333
8. R. Satolli The lesson from the debate on hormone replacement therapy Epidemiol Prev 26 2002 221 222
9. H. Roberts Hormone replacement therapy comes full circle BMJ 335 2007 219 220 Epub 2007 July 11
10. A. Battaggia, and R. Michieli Terapia ormonale sostitutiva in menopausa Rivista della Societ italiana di medicina generale 4 2007 11 23
11. A.R. Genazzani, M. Gambacciani, and T. Simoncini Menopausa e terapia ormonale sostituiva Giorn It Ost Gin 29 2007 213 222
12. Posizione scientifica di Societ di MG ed altri sulla TOS all'indomani dello studio WHI (ottobre 2002). Csermeg website. http://www.csermeg.it/index. php?ID-nodo=540, October 2002.
13. V.F. Meyer The medicalization of menopause: critique and consequences Int J Health Serv 31 4 2001 769 792
14. V.F. Meyer Medicalized menopause, US style Health Care Women Int 24 2003 822 830
15. P. Mosconi, S. Donati, C. Colombo, A. Mele, A. Liberati, and R. Satolli Informing women about hormone replacement therapy: the Consensus conference statement BMC Women's Health 9 2009 14 21
16. P. Mosconi, C. Colombo, R. Satolli, and A. Liberati PartecipaSalute, an Italian project to involve lay people, patients' associations and scientific-medical representatives on the health debate Health Expect 10 2007 194 204
17. Consensus conference on "Follow-up of Breast Cancer Patients" Ann Oncol 6 Suppl. 2 1995 S69 S70
18. Consensus conference "Modalit di trattamento riabilitativo del traumatizzato-cranio-encefalico in fase acuta, criteri di trasferibilit in strutture riabilitative e indicazioni a percorsi appropriati" Giornale Italiano Medicina Riabilitativa 15 1 2001 29 39 special issue
19. Consensus conference "Lo screening per infezione da virus dell'epatite C negli adulti in Italia" Roma January 2006 Istituto Superiore di Sanit http://www.pnlg.it/news10
20. Rating instrument of health information available at the Newcastle Institute of Public Health website, http://www.mediadoctor.org.au/content/ ratinginformation.jsp.
21. The "misuratesti" available at http://www.partecipasalute.it/ informati-bene/misura-testi-002.php.
22. G. Gigerenzer, W. Gaissmaier, E. Kurz-Milcke, L.M. Schwartz, and S. Woloshin Helping doctors and patients make sense of health statistics Psychol Sci Publ Interest 8 2 2007 53 96
23. C.L.L. Carling, D.T. Kristoffersen, and V.M. Montori The effect of alternative summary statistics for communicating risk reduction on decisions about taking statins: a randomized trial PloS Med 6 8 2009 e1000134
24. S. Hill, J. Spink, and D. Cadilhac Absolute risk representation in cardiovascular disease prevention: comprehension and preferences of health care consumers and general practitioners involved in a focus group study BMC Publ Health 10 2010 108 120
25. S. Donati, R. Cotichini, and P. Mosconi Menopause: knowledge, attitude and practice among Italian women Maturitas 63 3 2009 246 252
26. S. Denzer Communicating medical news - pitfalls of health care journalism N Engl J Med 360 2009 1 3
27. G. Schwitzer, G. Mudur, and D. Henry What are the roles and responsibilities of the media in disseminating health information? PLoS Med 2 2005 576 582
28. Does the media support or sabotage health? Lancet 373 2009 604
29. M.K. Canales, E.S. Breslau, D.E. Nelson, and R.R. Ballard-Barbash Did news reporters get it right? Translation of the 2002 hormone study findings Am J Prev 34 2008 61 68
30. D.L. Katz Medicine and media. State of the union? Am J Prev Med 34 2008 83 84
31. S.W. Fletcher, and G.A. Colditz Failure of estrogen plus progestin therapy for prevention JAMA 288 2002 366 368
32. JAMA media advisory: health risks outweigh benefits for combined estrogen plus progestin; clinical trial stopped early in major study 2002 American Medical Association Chicago
33. National Institutes of Health (NIH) News release: NHLBI stops trial of estrogen plus progestin due to increased breast cancer risk, lack of overall benefit 2002 National Heart, Lung, and Blood Institute (NHLBI) Bethesda, MD http://www.nhlbi.nih.gov/new/press/02-07-09.htm
34. NHLBI, NIH Press conference remarks: release of the results of the estrogen plus progestin trial of the Women's Health Initiative 2002 NHLBI, NIH Bethesda, MD http://www.nhlbi.nih.gov/health/women/kit.htm